TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Monash IVF Group Ltd ( (AU:MVF) ) has shared an update.
Monash IVF Group Limited has rejected a non-binding indicative proposal from a consortium led by Genesis Capital and WHSP Holdings to acquire 100% of its shares. The board determined that the offer, priced at $0.80 per share, undervalues the company and is not in the best interest of shareholders. The proposal included conditions such as exclusive due diligence and negotiation of transaction documentation, but the board found the offer to be opportunistic and lacking in value compared to similar market transactions. Monash IVF remains open to considering future proposals that provide compelling value for its shareholders.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$0.90 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited is a company in the healthcare industry, specializing in fertility services and assisted reproductive technologies. It focuses on providing in vitro fertilization (IVF) and related services to individuals and couples seeking to conceive.
Average Trading Volume: 2,325,118
Technical Sentiment Signal: Sell
Current Market Cap: A$237.7M
See more insights into MVF stock on TipRanks’ Stock Analysis page.